These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8810655)

  • 1. Tolerability and clinical efficacy of desmin in the treatment of superficial thrombovaricophlebitis.
    Andreozzi GM; Signorelli S; Di Pino L; Martini R; Marchitelli E; Pinto A; Romeo S; Zamboni V; Palazzini E
    Angiology; 1996 Sep; 47(9):887-94. PubMed ID: 8810655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postphlebitic syndrome: clinical activity and tolerability of desmin, new LMW dermatan sulfate.
    Andreozzi GM; Signorelli S; Di Pino L; Allegra C; Riccioni C; Cucinotta D; Manopulo R; Dettori AG; Megha A; Longo FN; Urbano O; Manganaro A; Buda D; Zamboni V; Palazzini E
    Angiology; 1996 Oct; 47(10):1001-10. PubMed ID: 8873586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of a new low molecular weight dermatan sulphate (Desmin) in healthy volunteers: repeated daily intramuscular administration of 400 mg for a week.
    Dettori AG; Zamboni V; Manotti C; Canova N; Barbanti M; Palazzini E
    Thromb Res; 1996 Jul; 83(1):103-9. PubMed ID: 8837309
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic activity of Desmin 370. Comparison with a high molecular weight dermatan sulfate.
    Barbanti M; Calanni F; Babbini M; Bergonzini G; Parma B; Marchi E; Wassermann A
    Thromb Res; 1993 Sep; 71(5):417-22. PubMed ID: 8236168
    [No Abstract]   [Full Text] [Related]  

  • 5. Liposomal heparin spray: a new formula in adjunctive treatment of superficial venous thrombosis.
    Górski G; Szopiński P; Michalak J; Marianowska A; Borkowski M; Geremek M; Trochimczuk M; Brotánek J; Sárník S; Seménka J; Wilkowski D; Noszczyk W
    Angiology; 2005; 56(1):9-17. PubMed ID: 15678251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of deep vein thrombosis with continuous intravenous low-molecular-weight dermatan sulphate (Desmin). A pilot study.
    Kretz JG; Chakfe N; Wiesel ML; Grunebaum L; Zamboni V; Palazzini E; Cazenave JP
    Thromb Res; 1996 Dec; 84(6):391-8. PubMed ID: 8987160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of Desmin, a low molecular weight dermatan sulfate, after subcutaneous administration to healthy volunteers.
    Miglioli M; Pironi L; Ruggeri E; Serra C; Zamboni V; Barbanti M; Canova N; Calanni F; Milani MR; Palazzini E
    Int J Clin Lab Res; 1997; 27(3):195-8. PubMed ID: 9352383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulodexide versus calcium heparin in the medium-term treatment of deep vein thrombosis of the lower limbs.
    Pinto A; Corrao S; Galati D; Arnone S; Licata A; Parrinello G; Maniscalchi T; Licata G
    Angiology; 1997 Sep; 48(9):805-11. PubMed ID: 9313630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group.
    Di Carlo V; Agnelli G; Prandoni P; Coccheri S; Gensini GF; Gianese F; Mannucci PM
    Thromb Haemost; 1999 Jul; 82(1):30-4. PubMed ID: 10456450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of the clinical experience with dermatan sulfate.
    Gianese F; Lucchelli PE
    Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacokinetics of LMW dermatan sulphate: long-term persistence of intact material.
    Dawes J
    Thromb Haemost; 1993 Apr; 69(4):339-43. PubMed ID: 8497846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study.
    Belcaro G; Nicolaides AN; Errichi BM; Cesarone MR; De Sanctis MT; Incandela L; Venniker R
    Angiology; 1999 Jul; 50(7):523-9. PubMed ID: 10431991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic characteristics of low-molecular-weight dermatan sulphate after subcutaneous administration in acute myocardial infarction.
    Traini AM; Cervi V; Melandri G; Palazzini E; Zamboni V; Semprini F; Candiotti N; Branzi A
    J Int Med Res; 1994; 22(6):323-31. PubMed ID: 7895895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
    Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
    J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of a low molecular weight dermatan sulphate (Desmin 370) in rat venous thrombosis--evidence for an anticoagulant-independent mechanism.
    Barbanti M; Calanni F; Milani MR; Marchi E; Semeraro N; Colucci M
    Thromb Haemost; 1993 Feb; 69(2):147-51. PubMed ID: 8456427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
    Dychter SS; Harrigan R; Bahn JD; Printz MA; Sugarman BJ; DeNoia E; Haughey DB; Fellows D; Maneval DC
    Clin Ther; 2014 Feb; 36(2):211-24. PubMed ID: 24486335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The feasibility and tolerability of prolonged treatment with low doses of heparin-calcium administered subcutaneously in infarct patients. A multicenter clinical study].
    Fernandez C; Proto C; Schiassi M; Scotti A
    Recenti Prog Med; 1993 Dec; 84(12):834-42. PubMed ID: 8108597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacotherapy of venous disease].
    Marx R
    Internist (Berl); 1967 Nov; 8(11):405-12. PubMed ID: 4174736
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence.
    Singham J; Greanya ED; Lau K; Erb SR; Partovi N; Yoshida EM
    Ann Hepatol; 2010; 9(2):166-71. PubMed ID: 20526010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose ranging study to evaluate dermatan sulphate in preventing deep vein thrombosis following total hip arthroplasty.
    Cohen AT; Phillips MJ; Edmondson RA; Skinner JA; Das SK; Cooper DJ; Thomas EM; Melissari E; Kakkar VV
    Thromb Haemost; 1994 Dec; 72(6):793-8. PubMed ID: 7740443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.